Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above

Publisher： Karger

E-ISSN： 1423-0143|36|1|131-138

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.36, Iss.1, 2012-10, pp. : 131-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Add-On Benefits of Amlodipine and Thiazide in Nondiabetic Chronic Kidney Disease Stage 1/2 Patients Treated with Valsartan

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 1, 2009-03 ,pp. : 51-58

Karger

Access to resources Recommend Favorite

Effect of an α-Adrenergic Blocker, and ACE Inhibitor and Hydrochlorothiazide on Blood Pressure and on Renal Function in Type 2 Diabetic Patients with Hypertension and Albuminuria

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 175-182

Karger

Access to resources Recommend Favorite

Initiation of Glucose-Based Peritoneal Dialysis Is Associated with Increased Prevalence of Metabolic Syndrome in Non-Diabetic Patients with End-Stage Renal Disease

By  

Blood Purification, Vol. 26, Iss. 5, 2008-09 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Blood Pressure Variability in Chronic Kidney Disease Patients

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 58-62

Karger

Access to resources Recommend Favorite

Polymorphic Genes for Kinin Receptors, Nephropathy and Blood Pressure in Type 2 Diabetic Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 2, 2003-01 ,pp. : 112-116

Karger

Access to resources Recommend Favorite